Viewing Study NCT02531451


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-02-24 @ 8:51 AM
Study NCT ID: NCT02531451
Status: COMPLETED
Last Update Posted: 2016-06-28
First Post: 2015-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effects of COX-inhibiting Drugs on Skeletal Muscle Adaptations to Resistance Exercise in Healthy Adults
Sponsor: Karolinska Institutet
Organization:

Study Overview

Official Title: The Effects of COX-inhibiting Drugs on Skeletal Muscle Adaptations to Resistance Exercise
Status: COMPLETED
Status Verified Date: 2016-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NSAID2015
Brief Summary: In this study, healthy human subjects (18-35 yrs) are be randomised to consume 1200 mg ibuprofen or 75 mg acetylsalicylic acid daily during a training period of 8 weeks. During these weeks, subjects perform 2-3 supervised strength training sessions (knee extensions). Before and after training, muscle volume is measured by MRI, and muscle strength is assessed by isokinetic and isoinertial ergometers. Muscle biopsies are obtained from m. vastus lateralis to study gene and protein expression of markers regulating muscle protein turnover and prostaglandin synthesis.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: